通光線纜(300265.SZ):預中標合計1.42億元合同
格隆匯4月30日丨通光線纜(300265.SZ)公佈,全資子公司江蘇通光強能輸電線科技有限公司、江蘇通光信息有限公司,於近日參與了“國家電網有限公司2025年第十三批採購(輸變電項目第二次線路裝置性材料招標採購)”、“國家電網有限公司2025年第十四批採購(輸變電項目第一次35-330千伏材料協議庫存招標採購)”,招標人爲國家電網有限公司。2025年4月30日,國家電網有限公司電子商務平臺發佈了相關的中標候選人公示。中標金額合計14234萬元。公司此次中標金額約佔2024年經審計營業收入總額的5.49%。本次中標對公司未來經營業績存在積極影響,其合同的履行不影響公司經營的獨立性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.